AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Conversation from CROI: Dr. Jonathan Mermin on PrEP and an AIDS-free Generation

Mermin YouTube still

At the recent 19th Conference on Retroviruses and Opportunistic Infections (CROI), Dr. Ron Valdiserri, Deputy Assistant Secretary of Health for Infectious Diseases, spoke with Dr. Jonathan Mermin, Director of CDC’s Division of HIV/AIDS Prevention. They discussed some of the significant findings from the conference including advances related to pre-exposure prophylaxis (PrEP) and the growing discussions…

New Frontiers in HIV Testing

Ronald Validserri

It is understandable why advances in the development of anti-HIV drugs have so dominated media stories about the AIDS epidemic in recent years. The advent of highly active antiretroviral therapy has had such a tremendous impact on HIV morbidity and mortality that early commentators of the phenomenon often referred to “the Lazarus effect” when describing…

The Impact of Missed Health Care Visits on HIV Outcomes and Mortality

Michael Holberg and Ron Valdiserri

At the 19th Conference on Retroviruses and Opportunistic Infections (CROI) [external disclaimer] this week, Dr. Ron Valdiserri, Deputy Assistant Secretary of Health for Infectious Diseases, spoke with Dr. Michael Horberg, Director of HIV/AIDS for Kaiser Permanente and a member of the Presidential Advisory Council on HIV/AIDS (PACHA). They discussed the paper Dr. Horberg is presenting…

Highlights from CROI 2012

Ronald Validserri

The 19th Conference on Retroviruses and Opportunistic Infections  (CROI) officially opened in Seattle on Monday afternoon, March 5th. Over 4,200 researchers, providers, community leaders, and advocates from 83 countries gathered at the Washington State Convention Center to hear the opening plenary session. The first presentation was from Dr. Dennis Burton, an internationally renowned expert in…

Advances in Science Advance the National HIV/AIDS Strategy

Ronald Valdiserri

The President has committed to supporting a National HIV/AIDS Strategy (NHAS) that is “grounded in the best science.” Scientific research efforts have greatly expanded our understanding of HIV/AIDS and produced a large number of critical tools and interventions to help us diagnose, prevent, and treat HIV. The past year has been particularly productive with important…

NIAID Advances Efforts to Restructure Clinical Trials Networks with Funding Announcements

NIAID wordle

Over the past year and a half, many of you followed the AIDS.gov blog post series Future Directions for NIAID HIV Research by Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Last week, NIAID advanced those efforts by issuing several requests for applications (RFAs)…

Community Engagement in NIAID’s HIV/AIDS Clinical Trials Networks

Future Directions for NIAID HIV Research: Consider and Comment

Since early in the HIV/AIDS epidemic, the National Institute of Allergy and Infectious Diseases (NIAID) has involved community representatives and advocates in the research process.   The nature and scope of the community’s involvement have grown over the years, but the rationale behind these efforts remains the same:  the people who might benefit from the research…

National HIV/AIDS and Aging Awareness Day: A Perspective from the National Institutes of Health

blog.aids.gov

Co-authored by Scott Proestel, M.D., Division of AIDS, National Institute of Allergy and Infectious Diseases, NIH

On September 18, 2011, we mark the fourth observance of National HIV/AIDS and Aging Awareness Day. The remarkable success of antiretroviral therapies in prolonging the lives of HIV-infected individuals who have access to and can tolerate these drugs has

Page 12 of 21« First...11121314...20...Last »